T1	Participants 103 121	healthy volunteers
T2	Participants 447 465	healthy volunteers
T3	Participants 611 662	Healthy male and female volunteers aged 18-75 years
T4	Participants 1439 1559	A total of 29 volunteers (19 aged â‰¥50 years; 8 women; 21 men) were evaluable for pharmacodynamic analysis (per protocol)
